with exogenous adiponectin can inhibit myocardial fibrosis. Therefore, the present study explored the influence of exogenous adiponectin on myocardial fibrosis induced by isoproterenol (ISO) in mice.
matErials and mEthods

Animal welfare
The study conformed to the guideline for the care and use of laboratory animals, PRC State Science and Technology Commission (Publication No. 1998-2, revised 2013) and was approved by the Animal Experiment Ethics Committee of Taishan Medical University.
Establishment and intervention of an animal model
Thirty male Sprague-Dawley mice were divided randomly into three equal groups: isoproterenol (ISO, n = 10), adiponectin and isoproterenol (APN + ISO, n = 10), and sham (n = 10). After adaptive feeding for 1 week, mice in the ISO group and APN + ISO group underwent intraperitoneal injection of ISO (7.5 mg/kg • d) for 3 days to induce myocardial fibrosis, [7] whereas the sham group received normal saline for 3 days. During the establishment of the model, two mice died in the ISO group, and 1 mouse died in the APN + ISO group, so were replaced.
From day 4, mice in the APN + ISO group underwent intraperitoneal injection of murine recombinant adiponectin (10 μg/kg • d; Cusabio Biotech, Wuhan, China), whereas mice in the sham and ISO groups were given normal saline by intraperitoneal injection for 32 days.
On day 35, mice were anesthetized using 10% choral hydrate (0.4 mg/kg). The sternal bone was cut from the midline and the heart was removed and rinsed using cold physiological (0.9%) saline. A portion of the left ventricle was cut down and fixed using 10% formaldehyde while the remainder of the myocardial tissue was stored at −80°C for reverse transcription-polymerase chain reaction (RT-PCR) and western blot analyses.
Assessment of paraffin sections of myocardial tissue
The formaldehyde-fixed myocardium was dehydrated, embedded in paraffin, stained by Sirius Red dye, and viewed under an optical microscope. Distribution of myocardial collagen was assessed under polarized light microscopy using Image Pro Plus v6.0 (Media Cybernetics, Rockville, MD, USA). The collagen volume fraction (CVF) was calculated as previously described. [8] Detection of type-I and type-III collagen messenger RNA by reverse transcription-polymerase chain reaction RT-PCR was used to semi-quantitatively assess the messenger RNA (mRNA) expression of type-I and type-III collagen fibers in myocardial tissue. Total RNA of heart tissue was extracted using TRIzol reagent. Total RNA (2 μl) was used to acquire the RT reaction solution (complementary DNA solution). PCR primer sequences were synthesized by Sangon Biotech, Shanghai, China. The upstream primer of the type-I collagen gene was 5′CACTGCCCTCCTGACGCATGG3′, the downstream primer was 5′CACGTCATCGCACACAGCCG 3 ′ , a n d t h e p r o d u c t l e n g t h w a s 1 4 8 b p . T h e upstream primer of the type-III collagen gene was 5′CCATTTGGAGAATGTTGTGCAAT3′, the downstream primer was 5′GGACATGATTCACAGATTCCAGG3′, and the product length was 197 bp. The upstream primer of the glyceraldehyde 3-phosphate dehydrogenase gene was 5′AGGTCGGTGTGAACGGATTTG3′, the downstream primer was 5′GGGGTCGTTGATGGCAACA3′ and the product length was 95 bp.
The standard procedures of amplification were as follows: predegeneration, 95°C for 30 s, one cycle; PCR reaction: 95°C for 5 s, 60°C for 34 s, 40 cycles. After amplification, RT-PCR products were analyzed using gel electrophoresis with Image-Pro Plus version 6.0 to obtain the computed tomography value and solubility temperature curve.
Protein expression of type-I and type-III collagen by western blotting
Myocardial tissue was ground in liquid nitrogen and homogenized in lysis buffer on ice. Lystates were centrifuged, and the supernatants were collected. The total protein concentration in supernatants was determined using a Bicinchoninic Acid Protein Assay kit (Pierce, Rockford, IL, USA). Fifty micrograms of each protein sample was separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. After blocking in 5% skimmed milk/TBS (1× TBS, 0.05% Tween 20) for 1 h, membranes were incubated with rabbit anti-mouse polyclonal antibodies against type-I or type-III collagen (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or mouse anti-β-actin (Sigma-Aldrich, St Louis, MO, USA) at 4°C overnight. Membranes were developed with horseradish peroxidase-labeled goat anti-rabbit IgG (Biomedical Technologies, Ward Hill, MA, USA). Immunoreactive proteins were visualized using enhanced chemiluminescence system. Immunoblots were quantified using Gel-pro Analyzer software (Quantity One; Bio-Rad, Hercules, CA, USA).
Statistical analyses
Continuous data are represented as mean ± standard deviation differences in continuous variables were analyzed using one-way analysis of variance. P < 0.05 was considered statistically significant. All statistical analyses were completed using SPSS version 13.0 (SPSS, Chicago, IL, USA).
rEsults
Characteristics of mice
All mice in the sham group survived, had normal hair color and smooth coats. In the ISO group, reduced activity, weight loss, and poor mental state were observed. The general characteristics of mice in the ISO + APN group were relatively intermediate between those in sham and ISO groups.
Assessment of myocardial fibrosis by polarized light microscopy
Heart tissues were stained by Sirius Red dye and observed under polarized light microscopy. In the sham group, less type-I and type-III collagen was distributed in myocardial interstitial tissue compared to that of the ISO and ISO + APN groups. Type-I collagen in myocardial interstitial tissue was significantly increased in the ISO group, was coarse and bright-red and was arranged and distributed in an inordinate manner. Type-III collagen was yellow-green and interwoven with type-I collagen. Compared with the ISO group, collagen in the myocardial interstitial tissue in the ISO + APN group was decreased significantly, but yellow-red-stained type-I collagen and green-stained type-III collagen could be seen [ Figure 1 ]. The CVF is a semi-quantitative index reflecting the degree of histological fibrosis. The CVF of the myocardium in the ISO + APN group was significantly lower than that in the ISO group [ Table 1 ].
Expression of type-I and type-III collagen messenger RNA in myocardial tissue by reverse transcription-polymerase chain reaction
Expression of type-I collagen mRNA in ISO and ISO + APN groups was significantly higher than that in the sham group (3.01 ± 0.78, 2.32 ± 0.82 vs. 1, respectively; P < 0.01).
Expression of type-I collagen mRNA in the ISO + APN group was significantly lower than that in the ISO group (2.32 ± 0.82 vs. 3.01 ± 0.78, respectively; P < 0.01). These findings suggested that APN could inhibit the myocardial fibrosis induced by ISO [ Table 2 ].
Expression of type-III collagen mRNA in the ISO group and ISO + APN group was significantly higher than that in the sham group (2.39 ± 0.70, 1.62 ± 0.57 vs. 1, respectively; P < 0.01). Interestingly, mRNA expression of type-III collagen in the ISO + APN group was significantly lower than that in the ISO group (1.62 ± 0.57 vs. 2.39 ± 0.70, respectively; P < 0.01), which suggested that APN could alleviate the myocardial fibrosis induced by ISO [ Table 3 ].
Expression of type-I and type-III collagen protein in the myocardium by the western blotting
Western blotting was used to quantify expression of type-I and type-III collagen protein in the myocardium. Expression of type-I collagen protein in the myocardium in the ISO + APN group was significantly higher than that in the sham group (0.73 ± 0.19 vs. 0.28 ± 0.15, respectively; P < 0.001), but it was significantly lower than the expression of type-I collagen protein in the ISO group (0.53 ± 0.17 vs. 0.73 ± 0.19, respectively; P < 0.001). Similar findings were noted regarding type-III collagen protein in the three groups [ Table 4 and Figure 2 ]. 
discussion
Myocardial fibrosis is a dynamic process and is a common endpoint of cardiovascular diseases. [9] Mechanisms of myocardial fibrosis and drug interventions have elicited widespread interest in researchers of cardiovascular disorders. [1] Our previous clinical study showed that serum levels of adiponectin were negatively related to the degree of myocardial fibrosis.
[5] The present study explored whether exogenous adiponectin can improve or inhibit the development of myocardial fibrosis in mice.
The mouse model of myocardial fibrosis was established by intraperitoneal injection of ISO. Excess exogenous ISO can cause necrosis and apoptosis of myocardial cells as well as fiber accumulation in myocardial interstitial tissue. ISO can also activate β-adrenergic receptors as well as the renin-angiotensin-aldosterone system (RAAS). Overactivation of the sympathetic nervous system can lead to the production and release of excessive amounts of catecholamines, which also cause necrosis and apoptosis of myocardial cells and excessive proliferation of fibrosis. [10] In this study, the collagen fibers of myocardial tissue were observed using polarization microscopy after staining with Sirius Red dye. The results revealed that ISO aggravated myocardial fibrosis and that supplementation with exogenous adiponectin could inhibit the myocardial fibrosis induced by ISO which was in accordance with previous research. [11] Calculations using the CVF demonstrated that exogenous adiponectin could antagonize the myocardial fibrosis induced byISO. Previous studies have verified that the mechanism of myocardial fibrosis induced by ISO in mice is related to activation of the RAAS system, [12] suggesting that inhibition of myocardial fibrosis by exogenous adiponectin could be associated with a depressed RAAS.
Myocardial fibrosis manifests as an accumulation of predominantly type-I and type-III collagen fibers in the myocardium. RT-PCR and western blotting were used to quantify the expression of protein and mRNA of type-I and type-III collagen to reflect the degree of myocardial fibrosis. We found that ISO could induce myocardial fibrosis, and that supplementation with exogenous adiponectin could inhibit the mRNA expression and protein synthesis of type-I and type-III collagen. These findings suggested that exogenous adiponectin could have inhibitory effects on the myocardial fibrosis induced by ISO.
We demonstrated that supplementation with exogenous adiponectin inhibited the myocardial fibrosis induced by ISO, but the mechanism by which this occurs is not clear. Studies have shown that overexpression of the adiponectin gene can improve the heart failure induced by angiotension-II in adiponectin gene knockout mice under cardiac overload, which suggests that adiponectin can improve myocardial remodeling. [13] Our finding that adiponectin can inhibit the myocardial fibrosis induced by ISO suggests that the mechanism may also be dependent on antagonistic effects against the activation of the local RAAS, consistent with the study published in 2014. [14] The depressed RAAS could reduce secretion of angiotensin-II and the synthesis of type-I and type-III collagen, thereby reversing myocardial remodeling. [15] conclusions Supplementation with exogenous adiponectin can inhibit the myocardial fibrosis induced by ISO. Adiponectin could be a protective factor against myocardial fibrosis. 
